These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
428 related articles for article (PubMed ID: 9103344)
21. Bioequivalence Between Generic and Branded Lamotrigine in People With Epilepsy: The EQUIGEN Randomized Clinical Trial. Berg M; Welty TE; Gidal BE; Diaz FJ; Krebill R; Szaflarski JP; Dworetzky BA; Pollard JR; Elder EJ; Jiang W; Jiang X; Switzer RD; Privitera MD JAMA Neurol; 2017 Aug; 74(8):919-926. PubMed ID: 28654954 [TBL] [Abstract][Full Text] [Related]
22. Bioequivalence of generic preparations of levothyroxine. Toft A Clin Endocrinol (Oxf); 2009 Oct; 71(4):603; author reply 603-4. PubMed ID: 19508682 [No Abstract] [Full Text] [Related]
23. A Double-Blind Placebo-Controlled Trial of Liquid Thyroxine Ingested at Breakfast: Results of the TICO Study. Cappelli C; Pirola I; Daffini L; Formenti A; Iacobello C; Cristiano A; Gandossi E; Agabiti Rosei E; Castellano M Thyroid; 2016 Feb; 26(2):197-202. PubMed ID: 26586610 [TBL] [Abstract][Full Text] [Related]
24. Comparative bioavailability of two oral L-thyroxine formulations after multiple dose administration in patients with hypothyroidism and its relation with therapeutic endpoints and dissolution profiles. Vaisman M; Spina LD; Eksterman LF; dos Santos MJ; Lima JS; Volpato NM; da Silva RL; de Brito AP; Noël F Arzneimittelforschung; 2001; 51(3):246-52. PubMed ID: 11304941 [TBL] [Abstract][Full Text] [Related]
25. Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism: a randomized controlled trial. Clyde PW; Harari AE; Getka EJ; Shakir KM JAMA; 2003 Dec; 290(22):2952-8. PubMed ID: 14665656 [TBL] [Abstract][Full Text] [Related]
26. Generic vs name brand L-thyroxine products: interchangeable or still not? Hennessey JV J Clin Endocrinol Metab; 2013 Feb; 98(2):511-4. PubMed ID: 23390262 [No Abstract] [Full Text] [Related]
27. Biologic blood markers reflecting thyroid hormone effect at peripheral tissue level in patients receiving levothyroxine replacement for hypothyroidism. Földes J; Tarján G; Bános C; Németh J; Varga F; Büki B Acta Med Hung; 1991; 48(1-2):33-43. PubMed ID: 1813856 [TBL] [Abstract][Full Text] [Related]
28. Effects of evening vs morning levothyroxine intake: a randomized double-blind crossover trial. Bolk N; Visser TJ; Nijman J; Jongste IJ; Tijssen JG; Berghout A Arch Intern Med; 2010 Dec; 170(22):1996-2003. PubMed ID: 21149757 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of the therapeutic efficacy of different levothyroxine preparations in the treatment of human thyroid disease. Klein I; Danzi S Thyroid; 2003 Dec; 13(12):1127-32. PubMed ID: 14751033 [TBL] [Abstract][Full Text] [Related]
30. Levothyroxine: therapeutic use and regulatory issues related to bioequivalence. Wartofsky L Expert Opin Pharmacother; 2002 Jun; 3(6):727-32. PubMed ID: 12036412 [TBL] [Abstract][Full Text] [Related]
31. A bioequivalence study of levothyroxine tablets versus an oral levothyroxine solution in healthy volunteers. Yannovits N; Zintzaras E; Pouli A; Koukoulis G; Lyberi S; Savari E; Potamianos S; Triposkiadis F; Stefanidis I; Zartaloudis E; Benakis A Eur J Drug Metab Pharmacokinet; 2006; 31(2):73-8. PubMed ID: 16898074 [TBL] [Abstract][Full Text] [Related]
32. Adherence to thyroid hormone replacement therapy: a retrospective, claims database analysis. Hepp Z; Wyne K; Manthena SR; Wang S; Gossain V Curr Med Res Opin; 2018 Sep; 34(9):1673-1678. PubMed ID: 29874941 [TBL] [Abstract][Full Text] [Related]
33. Effects of Levothyroxine Administration and Withdrawal on the Hypothalamic-Pituitary-Thyroid Axis in Euthyroid Dogs. Ziglioli V; Panciera DL; Troy GC; Monroe WE; Boes KM; Refsal KR J Vet Intern Med; 2017 May; 31(3):705-710. PubMed ID: 28432797 [TBL] [Abstract][Full Text] [Related]
34. Levothyroxine sodium tablets: chemical equivalence and bioequivalence. Curry SH; Gums JG; Williams LL; Curry RW; Wolfson BB Drug Intell Clin Pharm; 1988; 22(7-8):589-91. PubMed ID: 3046889 [TBL] [Abstract][Full Text] [Related]
35. Biologic markers in blood reflecting thyroid hormone effect at peripheral tissue level in patients receiving levothyroxine replacement for hypothyroidism. Földes J; Tarján G; Bános C; Németh J; Varga F; Büki B Exp Clin Endocrinol; 1992; 99(3):129-33. PubMed ID: 1526260 [TBL] [Abstract][Full Text] [Related]
36. Thyroid hormone replacement therapy in primary hypothyroidism: a randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone. Escobar-Morreale HF; Botella-Carretero JI; Gómez-Bueno M; Galán JM; Barrios V; Sancho J Ann Intern Med; 2005 Mar; 142(6):412-24. PubMed ID: 15767619 [TBL] [Abstract][Full Text] [Related]
37. Hypothyroidism resulting from generic levothyroxine failure. Dong BJ; Brown CH J Am Board Fam Pract; 1991; 4(3):167-70. PubMed ID: 2053456 [TBL] [Abstract][Full Text] [Related]
38. Bioequivalence of two commercially available levothyroxine-Na preparations in athyreotic patients. Gottwald R; Lorkowski G; Petersen G; Schnitzler M; Lücker PW Methods Find Exp Clin Pharmacol; 1994 Nov; 16(9):645-50. PubMed ID: 7746026 [TBL] [Abstract][Full Text] [Related]
39. Estimation of a physiologic replacement dose of levothyroxine in elderly patients with hypothyroidism. Davis FB; LaMantia RS; Spaulding SW; Wehmann RE; Davis PJ Arch Intern Med; 1984 Sep; 144(9):1752-4. PubMed ID: 6433829 [TBL] [Abstract][Full Text] [Related]
40. Generic lamotrigine versus brand-name Lamictal bioequivalence in patients with epilepsy: A field test of the FDA bioequivalence standard. Ting TY; Jiang W; Lionberger R; Wong J; Jones JW; Kane MA; Krumholz A; Temple R; Polli JE Epilepsia; 2015 Sep; 56(9):1415-24. PubMed ID: 26201987 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]